ALTAMURA, CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.315
EU - Europa 430
AS - Asia 136
Totale 1.881
Nazione #
US - Stati Uniti d'America 1.314
DE - Germania 113
SE - Svezia 103
IT - Italia 97
CN - Cina 75
RU - Federazione Russa 42
SG - Singapore 40
GB - Regno Unito 32
FR - Francia 14
FI - Finlandia 13
VN - Vietnam 10
IN - India 6
UA - Ucraina 5
BE - Belgio 4
TR - Turchia 3
IE - Irlanda 2
NL - Olanda 2
AT - Austria 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ID - Indonesia 1
PH - Filippine 1
Totale 1.881
Città #
Fairfield 217
Ashburn 141
Chandler 133
Houston 111
Woodbridge 107
Nyköping 86
Cambridge 73
Wilmington 60
Ann Arbor 58
Seattle 58
Bari 39
Singapore 31
Beijing 23
Roxbury 23
Lawrence 21
Inglewood 20
New York 20
Des Moines 17
Jacksonville 17
San Diego 15
Nanjing 14
Santa Clara 12
Dong Ket 10
Paris 9
Los Angeles 8
Washington 8
Princeton 7
Montignoso 6
Pune 6
Brooklyn 5
Helsinki 5
Wuhan 5
Dearborn 4
Mottola 4
Nanchang 4
Guangzhou 3
Milan 3
Shenyang 3
Boardman 2
Brussels 2
Chicago 2
Dublin 2
Esslingen am Neckar 2
Florence 2
Hebei 2
Hohenstein-Ernstthal 2
Jiaxing 2
London 2
Magliano Alpi 2
Münster 2
Naples 2
Norwalk 2
Perugia 2
Redwood City 2
Rome 2
San Mateo 2
Shanghai 2
Taranto 2
Tianjin 2
Triggiano 2
Vinovo 2
Waanrode 2
Acquaviva delle Fonti 1
Andria 1
Augusta 1
Brno 1
Castelnuovo Rangone 1
Changsha 1
Denver 1
Fasano 1
Fort Worth 1
Giresun 1
Gravina In Puglia 1
Jinan 1
Krasnoyarsk 1
Kunming 1
Leawood 1
Lianyun 1
Makati 1
Marseille 1
Martina Franca 1
Miami 1
Modugno 1
Monmouth Junction 1
Monte San Giovanni Campano 1
Nettuno 1
New Bedfont 1
Padova 1
Phoenix 1
Prescot 1
Reston 1
San Francisco 1
San José 1
Sannicandro di Bari 1
Settingiano 1
Shenzhen 1
Simi Valley 1
Tappahannock 1
Vicenza 1
Vienna 1
Totale 1.472
Nome #
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 158
ClC-1 chloride channels: state-of-the-art research and future challenges 151
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 137
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 130
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 110
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 110
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 108
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 107
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels 97
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 96
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 67
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 62
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 62
Skeletal muscle ClC-1 chloride channels in health and diseases 56
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 56
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 45
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 45
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 42
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 39
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine 36
Emerging roles for ion channels in ovarian cancer: Pathomechanisms and pharmacological treatment 34
Buprenorphine may be effective for treatment of paramyotonia congenita 34
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 32
null 29
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 29
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy 29
Ion Channel Involvement in Tumor Drug Resistance 22
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 21
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 12
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 11
Drug repurposing in skeletal muscle ion channelopathies 10
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 9
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 8
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 7
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 7
Target mutation-driven drug discovery 7
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 7
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 5
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 4
Totale 2.031
Categoria #
all - tutte 9.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 21 42 26 22 23 27 31 34 35 10
2020/2021440 34 26 32 48 32 42 47 21 31 64 32 31
2021/2022239 17 15 5 20 4 14 4 11 16 40 42 51
2022/2023356 35 54 33 17 24 52 11 54 46 9 14 7
2023/2024197 8 30 15 21 25 61 3 4 5 8 8 9
2024/202583 42 4 37 0 0 0 0 0 0 0 0 0
Totale 2.031